Back To Search Results

Bacterial Pharyngitis

Editor: Matthew Graber Updated: 7/3/2023 11:25:00 PM


Pharyngitis, more commonly described as sore throat, represents inflammation or irritation of the posterior oropharynx. While the majority of cases arise by either non-infectious or non-bacterial causes, bacteria are responsible for a substantial portion of pharyngeal infections, and these infections present differently, have different complications, and require different treatment.[1] Effectively identifying bacterial pharyngitis and knowing when to evaluate for its more atypical causes is an important skill for any front-line or specialist provider to avoid both unnecessary treatment and the morbidity arising from missed or improperly treated infections.[2]


Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care


Acute pharyngitis is quite common in both children and adults, usually arising from non-infectious (i.e., seasonal allergies and acid reflux) or non-bacterial (i.e., viral) causes.[1] However, when the cause is bacterial, pharyngitis is most often caused by group A beta-hemolytic Streptococcus (GABHS), commonly referred to as strep throat.[3] GABHS is transmitted via airborne transmission or ingestion and is associated with acute and delayed complications, which will be described later in the article.

Other bacteria may also cause pharyngitis, including streptococcus groups C and G, but due to the difficulty of distinguishing colonization from infection, it is difficult to quantify the relative rates of these bacterial causes.[4] Sexually transmitted infections, such as Neisseria gonorrhea and Chlamydia trachomatis, should be considered if risk factors are present, though they are typically asymptomatic.[5] Rarer infections, such as Yersinia pestis and Corynebacterium diphtheriae, could be considered if recent exposure to endemic areas is suspected.[6][7]


Sore throat is an extremely common presenting complaint in providers' offices, emergency departments, and urgent care centers.[8] The complaint is particularly common among pediatric patients, who account for around half of all cases. Among adults, bacterial pharyngitis is less common with age, with most cases occurring in patients less than 40 years old.[9][10] Bacterial causes are dominated by Group A strep infections, again more commonly among children, who are also more likely to suffer from acute and delayed complications of strep infections.[4][11]

The other bacterial causes of sore throat are rarer but are highly associated with risk factors. While gonorrhea and chlamydia are frequently asymptomatic, a pharyngeal STI is present in nearly 10% of those with some risk factors.[5] Further, cases of diphtheria are confined to unvaccinated populations or to regions of the world where the disease remains endemic.[7]


In bacterial pharyngitis, bacteria invade the mucosal tissues of the pharynx directly. Extracellular factors such as proteases facilitate the tissue invasion and cause the inflammation that elicits swelling, exudates, fever, and pain with swallowing.[12][13] As it is experienced more broadly, the inflammation may also contribute to symptoms of otitis and sinusitis, even when those areas have not been infected with the same bacteria.

Streptococcus specifically expresses a hyaluronic acid capsule that matches host tissue and prevents the typical immune response, making treatment particularly dependent on antibiotics.[14] While untreated bacterial infections can penetrate more deeply, leading to more serious infections like cellulitis, abscess, or bacteremia, this is much less likely than prior to common antibacterial treatment.

Some bacteria produce exotoxins, which can intensify the local tissue destruction or cause severe systemic symptoms. A local exotoxin can cause diphtheria’s pathognomonic pseudomembrane, and systemic toxins can cause scarlet fever and the rare toxic shock syndrome associated with streptococcus.[15][16]

Likely due to molecular similarities between streptococcus and host tissues, there is an additional risk for noninfectious complications of this pharyngitis. Rheumatic fever and glomerulonephritis can follow a streptococcal infection, likely resulting from molecular mimicry and multi-factorial autoimmune reactions, respectively.[15]

History and Physical

As with most medical conditions, the diagnosis and management of bacterial pharyngitis depend on collecting an effective history and performing a directed physical exam. Bacterial pharyngitis is most commonly acute in onset with a relatively isolated severe sore throat, potentially with associated symptoms like the scarlatiniform rash or abdominal pain.[3][4] Providers should collect information about associated symptoms, time course, previous history, and risk factors. Additional upper respiratory symptoms, such as congestion, cough, and eye irritation, suggest viral infections or seasonal allergies as more likely etiologies.[2] Seasonally recurrent or persistent symptoms with no fever favor allergic etiologies. History of acid reflux, positional exacerbation, and association with recent irritant foods, caffeine, or alcohol favors gastroesophageal reflux disease. Risk factors like high-risk sexual behavior or close family with strep throat may lower the bar for potential testing.

An appropriate physical exam would include assessing vital signs for fever and evidence of clinical instability, evaluating the ears, conjunctiva, and nares for evidence of the symptoms described or alternative explanations for a potential fever. Evaluation of the oropharynx and neck should assess for swelling and exudates of the tonsils and pharynx and lymphadenopathy. Exudates or a pseudomembrane favors a bacterial etiology, as do swollen and tender lymph nodes. More diffuse swelling of the conjunctiva, nasal turbinates, and pharynx, especially associated with post-nasal drip, favor non-bacterial etiologies.[17] Especially in children, a skin exam is appropriate to look for the red, sandpapery rash of scarlet fever or evidence of other exanthems that might indicate an alternative infection.


Diagnosis of bacterial pharyngitis should not be made based solely on clinical exam findings but rather on a combination of an objective clinical exam leading to appropriate laboratory testing.[2][17] Several tools are available to help remove subjectivity from the clinical exam, and a variety of point-of-care and laboratory tests have been developed to confirm clinical indications.

The first developed of the clinal tools was the Centor criteria, the purpose of which is to evaluate the likelihood of a streptococcal infection. Those criteria include tonsillar exudates, fever of more than 100.4 F (38 C), tender anterior cervical lymphadenopathy, and the absence of a cough. Patients with limited Centor criteria (0-1) are unlikely to have a streptococcal infection, and testing is unnecessary. Patients with many of the criteria (3-4) are more likely to have the infection and warrant point-of-care or laboratory testing.[18] The McIsaac criteria modify the original Center criteria to account for age differences by adding a point for patients ages 3 to 14 and subtracting a point for patients 45 and over.[18] The FeverPAIN criteria include fever, tonsillar exudates, severe inflammation, onset within three days, and the absence of cough or coryza. Again, patients with limited criteria (0-1) are unlikely to have strep infections, and those with many criteria (4 or more) are more likely.[19]

A rapid antigen detection test (RADT) is a point of care test used to check for streptococcus in those patients whose infections cannot confidently be attributed to other causes. Its specificity is around 95%, so a positive RADT result requires no further testing. However, it has a sensitivity ranging from 70 to 90%, so, in patients with many indications of bacterial infection, a negative RADT should be confirmed with a traditional throat culture.[20]

A bacterial throat culture is a gold standard for diagnosing a streptococcal infection. Unfortunately, the results are not available for up to a day or two. This is especially problematic in patients for whom follow up is more difficult, such as emergency department patients or those with unstable contact information.

A Nucleic acid amplification test (NAAT) for Neisseria gonorrhea and Chlamydia trachomatis can be used to test for pharyngeal infections. Though it is not FDA-approved, the CDC endorses its use for appropriate screening or diagnosis as it is more sensitive than traditional cultures. While pharyngeal gonorrhea and chlamydia are unlikely to cause symptoms, NAAT swab testing would be appropriate in patients with high-risk or in cases where the sore throat does not respond appropriately to standard treatment.[21]

Blood tests such as leukocyte count and C-reactive protein may also be performed to evaluate a patient's clinical stability or the risk of systemic illness. Anti-streptococcal antibody testing will not help to diagnose acute infections since they are not immediately present and are not reliably persistent.[22]

Imaging is appropriate only in circumstances where the patient demonstrates instability consistent with an abscess or other severe etiology of sore throat, in which case the patient should be transferred to an emergency or inpatient setting.[23]

Even those meeting all criteria for the clinical evaluation tools have only a 50 to 65% chance of having a streptococcal infection. Because of this, the Infectious Disease Society of America recommends not relying on clinical evaluation alone to determine treatment. While past recommendations endorsed the use of empiric antibiotics for patients with high scores, the most recent recommendations, noting the increased prevalence and accuracy of point-of-care testing and potentially limited morbidity of untreated infections, recommend confirming infections before treatment.[2] This recommendation is not universally accepted but can serve to temper the aggressive use of antibiotics without testing.

Treatment / Management

Bacterial pharyngitis should be treated with appropriate antibiotics once the infection has been confirmed. The symptoms for any pharyngitis should be additionally treated with nonsteroidal anti-inflammatory drugs or acetaminophen for antipyresis and analgesia.

For GABHS, the first-line antibiotic treatments are penicillins because they are inexpensive and effective, and no significant antibiotic resistance has been discovered. Penicillin V and amoxicillin are typical. Cephalosporins are also appropriate for patients with a mild penicillin allergy or when penicillin is not available. Treatment with the narrowest possible spectrum cephalosporin is recommended to avoid developing resistance. In patients with a more severe allergy to penicillin, treatment with azithromycin can be appropriate, but macrolide resistance has been increasing. Finally, when resistance to azithromycin is known, clindamycin can be used to treat those with severe penicillin allergies, though it too faces resistance and has higher rates of intolerance due to taste, intestinal side effects and possible opportunistic bacterial infections such as with clostridium difficile.[2][3](A1)

Cases of pharyngeal gonorrhea or chlamydia should be treated as would be genital infections, typically co-treating for both gonorrhea and chlamydia with 250 mg of ceftriaxone intramuscularly and 1000 mg of azithromycin per orally.[21]

Cases of diphtheria should be reported to the CDC and are best treated with antibiotics (erythromycin or penicillin) and antitoxin (available through the CDC). Patients should be placed on respiratory droplets and contact isolation until two consecutive cultures taken 24 hours apart are both negative.[24](B3)

Cases of Yersinia pestis should be treated with appropriate antibiotics (aminoglycosides or tetracyclines, primarily), and patients should be placed on respiratory droplet precautions until cultures are negative and antibiotics have been given for at least 48 hours.[25](B3)

Local infectious complications of acute pharyngitides, such as a peritonsillar abscess, should be managed in a hospital setting, where interventions can be made with appropriate surgical and specialist support, such as availability of rapid intubation if a patient's airway becomes compromised.[23]

Differential Diagnosis

As noted, the majority of cases of acute bacterial pharyngitis are either noninfectious or nonbacterial. When considering the possibility of bacterial pharyngitis, providers should also consider:

  • Allergic reaction to environmental factors like pollen, indoor or outdoor pollutants or medications
  • Irritant pharyngitis due to gastroesophageal reflux or smoking
  • Traumatic pharyngitis due to excessive shouting, snoring, or recent tracheal intubation
  • Aphthous ulcers
  • Viral pharyngitis due to common viral upper respiratory pathogens like adeno-, rhino-, or coronavirus
  • Viral pharyngitis due to more serious pathogens like infectious mononucleosis, pandemic coronavirus or HIV
  • Fungal infections such as esophageal candidiasis
  • Bacterial complications such as lymphangitis or peritonsillar or retropharyngeal abscess


Most cases of acute bacterial pharyngitis are self-limiting. If GABHS infection is confirmed and treated with an appropriate antibiotic, the prognosis is good. Rarely, a patient may develop one of the complications.[26]Some patients may experience a repeat infection within one month of antibiotic treatment. This is often due to non-compliance with antibiotic medication, though it may result from repeat exposure. If it occurs, the patient can be treated with an alternative antibiotic, often with broader coverage, and the importance of adherence to treatment and avoidance of risks can be emphasized. The most commonly used antibiotics are amoxicillin-clavulanic acid, clindamycin, intramuscular penicillin G. If a first-generation cephalosporin had been used initially, antibiotics are typically escalated to a third-generation cephalosporin.[2]

Sexually transmitted pharyngeal infections are easily treated and most commonly asymptomatic.[21]

The rare infections of diphtheria and Yersinia pestis are quite treatable when basic medical resources are available, though they may be associated with poor prognosis since most cases would develop in highly under-resourced settings.[24][25] In the regions where it occurs, diphtheria could have mortality ranging from 3-20%, often related to resultant myocarditis or severely inadequate access to care.[27] Similarly, the mortality associated with Yersinia pestis ranges from less than 15%, when treated, to 60 to 100% when left untreated.[28]


Different complications may develop from bacterial pharyngitis, depending on the specific bacterial cause. Generally, a bacterial infection can spread, leading to abscess, cellulitis, lymphadenitis, meningitis, and bacteremia. It will also cause local swelling, which can lead to inflammation due to occlusions, such as sinusitis and otitis media.[12][13]

While streptococcal infections are typically self-limited, it is important to diagnose and treat them with antibiotics since GABHS infections may lead to serious complications. Exotoxins produced by GABHS can produce scarlet fever or toxic shock syndrome. An autoimmune response triggered by a GABHS infection can lead to acute rheumatic fever.[15][16] Though post-streptococcal glomerulonephritis also results from dysfunctional immune response, it is not prevented by appropriate antibiotic treatment.[2]

Pharyngeal sexually transmitted infections, such as gonorrhea and chlamydia, are often asymptomatic and do not typically lead to complications for the host but are contagious, leading to infections for partners that can be symptomatic and can lead to complications such as pelvic inflammatory disease, orchitis, and prostatitis.[29]

Diphtheria's primary pathology arises from toxin production. The toxin produces necrosis and inflammation, can lead to respiratory compromise through swelling of the upper airway, cardiovascular compromise through toxin-induced myocarditis, and local or systemic paralysis through neurologic toxicity.[24][25]

Pharyngitis due to Yersinia pestis represents a potential site of inoculation rather than a typical initial presentation. Plague typically progresses to severe lymphadenitis, followed by potential dissemination.[30]

Deterrence and Patient Education

Bacterial pharyngitis, like most infectious agents, can be prevented with proper hygiene protocols, such as hand washing, not sharing food or beverages, and covering the mouth while sneezing. Patients should be educated on the importance of completing an antibiotic course as prescribed. Doing so will increase the efficacy of treatment, prevent recurrence of infections, and prevent antimicrobial resistance.

Enhancing Healthcare Team Outcomes

The primary areas for improving outcomes around bacterial pharyngitis are in accurately identifying and responsibly treating the cause of patients' pharyngitides. Resulting from patients' expectations as well as limitations in the sensitivity and speed of current testing, current practice is often to inappropriately treat what is likely nonbacterial pharyngitis with antibiotics.[31] Following guidance from the Infectious Diseases Society of America, the American Academy of Pediatrics, and the Centers for Disease Control and Prevention, health care teams should embrace shared decision making with their patients and families.[2]

Clinicians, nurses, pharmacists, and their teams have a responsibility to honestly discuss both the benefits and limitations of the tests they perform and the antibiotics and other treatments they may prescribe. Accommodating honest health concerns as well as the logistical difficulties of office visits, testing, and absence from work or school is essential. Health care teams should discuss options for treatment, including observation alone, immediate antibiotic treatment, and writing a delayed prescription to allow patients to receive antibiotics in the future without returning to be seen in person. The context of this care also warrants the expansion of remote care options, such as video- or phone-based visits.[2][32][33][34]

Clinical features alone are not sufficient to diagnose streptococcal pharyngitis and should be supplemented with RADT or throat culture. A positive RADT does not require confirmation.[2] [Level 1]

Routine confirmation of negative RADT with a throat culture is not necessary for adults.[2] [Level 2]

Patients whose pharyngitis is very likely of viral etiology should not be tested with either RADT or throat culture.[2] [Level 1]



Kociolek LK, Shulman ST. In the clinic. Pharyngitis. Annals of internal medicine. 2012 Sep 4:157(5):ITC3-1 - ITC3-16     [PubMed PMID: 22944886]


Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C, Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Nov 15:55(10):e86-102. doi: 10.1093/cid/cis629. Epub 2012 Sep 9     [PubMed PMID: 22965026]

Level 1 (high-level) evidence


Kalra MG, Higgins KE, Perez ED. Common Questions About Streptococcal Pharyngitis. American family physician. 2016 Jul 1:94(1):24-31     [PubMed PMID: 27386721]


Varosy PD, Newman TB. Acute pharyngitis. The New England journal of medicine. 2001 May 10:344(19):1479; author reply 1480     [PubMed PMID: 11357847]

Level 3 (low-level) evidence


Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, Bernstein K, Gratzer B, Jespersen M, Kerani R, Mettenbrink C, Mohamed M, Pathela P, Schumacher C, Stirland A, Stover J, Tabidze I, Kirkcaldy RD, Weinstock H. Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 Jun:58(11):1564-70. doi: 10.1093/cid/ciu184. Epub 2014 Mar 18     [PubMed PMID: 24647015]

Level 2 (mid-level) evidence


Butler T. Plague gives surprises in the first decade of the 21st century in the United States and worldwide. The American journal of tropical medicine and hygiene. 2013 Oct:89(4):788-93. doi: 10.4269/ajtmh.13-0191. Epub 2013 Sep 16     [PubMed PMID: 24043686]

Level 3 (low-level) evidence


Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. European journal of epidemiology. 1995 Feb:11(1):107-17     [PubMed PMID: 7489768]


Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. National health statistics reports. 2008 Aug 6:(8):1-29     [PubMed PMID: 18958997]


André M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, Mölstad S, Runehagen A, Lundborg CS, Wahlström R, Swedish Study Group on Antibiotic Use. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scandinavian journal of infectious diseases. 2002:34(12):880-6     [PubMed PMID: 12587619]


Danchin MH, Rogers S, Kelpie L, Selvaraj G, Curtis N, Carlin JB, Nolan TM, Carapetis JR. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics. 2007 Nov:120(5):950-7     [PubMed PMID: 17974731]

Level 2 (mid-level) evidence


Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart (British Cardiac Society). 2008 Dec:94(12):1534-40. doi: 10.1136/hrt.2007.141309. Epub 2008 Jul 31     [PubMed PMID: 18669552]

Level 2 (mid-level) evidence


Eccles R. Understanding the symptoms of the common cold and influenza. The Lancet. Infectious diseases. 2005 Nov:5(11):718-25     [PubMed PMID: 16253889]

Level 3 (low-level) evidence


Bathala S, Eccles R. A review on the mechanism of sore throat in tonsillitis. The Journal of laryngology and otology. 2013 Mar:127(3):227-32. doi: 10.1017/S0022215112003003. Epub 2013 Jan 15     [PubMed PMID: 23317998]


Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proceedings of the National Academy of Sciences of the United States of America. 1991 Oct 1:88(19):8317-21     [PubMed PMID: 1656437]

Level 3 (low-level) evidence


Soderholm AT, Barnett TC, Sweet MJ, Walker MJ. Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies. Journal of leukocyte biology. 2018 Feb:103(2):193-213. doi: 10.1189/jlb.4MR0617-227RR. Epub 2017 Dec 29     [PubMed PMID: 28951419]


Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Critical care clinics. 2013 Jul:29(3):651-75. doi: 10.1016/j.ccc.2013.03.012. Epub     [PubMed PMID: 23830657]

Level 3 (low-level) evidence


Ebell MH, Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? JAMA. 2000 Dec 13:284(22):2912-8     [PubMed PMID: 11147989]


Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Archives of internal medicine. 2012 Jun 11:172(11):847-52. doi: 10.1001/archinternmed.2012.950. Epub     [PubMed PMID: 22566485]

Level 2 (mid-level) evidence


Little P, Hobbs FD, Moore M, Mant D, Williamson I, McNulty C, Lasseter G, Cheng MY, Leydon G, McDermott L, Turner D, Pinedo-Villanueva R, Raftery J, Glasziou P, Mullee M, PRISM investigators. PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study. Health technology assessment (Winchester, England). 2014 Jan:18(6):vii-xxv, 1-101. doi: 10.3310/hta18060. Epub     [PubMed PMID: 24467988]

Level 2 (mid-level) evidence


Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. The Cochrane database of systematic reviews. 2016 Jul 4:7(7):CD010502. doi: 10.1002/14651858.CD010502.pub2. Epub 2016 Jul 4     [PubMed PMID: 27374000]

Level 1 (high-level) evidence


Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2015 Jun 5:64(RR-03):1-137     [PubMed PMID: 26042815]


Hysmith ND,Kaplan EL,Cleary PP,Johnson DR,Penfound TA,Dale JB, Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci. Journal of the Pediatric Infectious Diseases Society. 2017 Jun 1;     [PubMed PMID: 28204534]


Galioto NJ. Peritonsillar Abscess. American family physician. 2017 Apr 15:95(8):501-506     [PubMed PMID: 28409615]


Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1993 Jan:16(1):59-68     [PubMed PMID: 8448320]

Level 3 (low-level) evidence


Koirala J. Plague: disease, management, and recognition of act of terrorism. Infectious disease clinics of North America. 2006 Jun:20(2):273-87, viii     [PubMed PMID: 16762739]

Level 3 (low-level) evidence


WANNAMAKER LW, RAMMELKAMP CH Jr, DENNY FW, BRINK WR, HOUSER HB, HAHN EO, DINGLE JH. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. The American journal of medicine. 1951 Jun:10(6):673-95     [PubMed PMID: 14837911]


Kadirova R,Kartoglu HU,Strebel PM, Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. The Journal of infectious diseases. 2000 Feb;     [PubMed PMID: 10657201]

Level 2 (mid-level) evidence


Campbell GL, Hughes JM. Plague in India: a new warning from an old nemesis. Annals of internal medicine. 1995 Jan 15:122(2):151-3     [PubMed PMID: 7992992]


Eschenbach DA, Buchanan TM, Pollock HM, Forsyth PS, Alexander ER, Lin JS, Wang SP, Wentworth BB, MacCormack WM, Holmes KK. Polymicrobial etiology of acute pelvic inflammatory disease. The New England journal of medicine. 1975 Jul 24:293(4):166-71     [PubMed PMID: 806017]


Welty TK, Grabman J, Kompare E, Wood G, Welty E, Van Duzen J, Rudd P, Poland J. Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. The Western journal of medicine. 1985 May:142(5):641-6     [PubMed PMID: 4013279]

Level 3 (low-level) evidence


Barnett ML, Linder JA. Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. JAMA internal medicine. 2014 Jan:174(1):138-40. doi: 10.1001/jamainternmed.2013.11673. Epub     [PubMed PMID: 24091806]


Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016 Feb 9:315(6):562-70. doi: 10.1001/jama.2016.0275. Epub     [PubMed PMID: 26864410]

Level 1 (high-level) evidence


Harris AM, Hicks LA, Qaseem A, High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention. Annals of internal medicine. 2016 Mar 15:164(6):425-34. doi: 10.7326/M15-1840. Epub 2016 Jan 19     [PubMed PMID: 26785402]


Norton LE, Lee BR, Harte L, Mann K, Newland JG, Grimes RA, Myers AL. Improving Guideline-Based Streptococcal Pharyngitis Testing: A Quality Improvement Initiative. Pediatrics. 2018 Jul:142(1):. pii: e20172033. doi: 10.1542/peds.2017-2033. Epub 2018 Jun 20     [PubMed PMID: 29925574]

Level 2 (mid-level) evidence